Sonrai White Paper

Build Versus Buy:  Multi-Omic Platform

Managing the abundance of multi-omic data in precision medicine is challenging and complex. In this white paper, we help you evaluate whether you should invest in building your own in-house solution or purchase a cloud-based research platform. Our expert, Dr Craig Davison, explores the advantages and disadvantages of both options and includes a checklist of criteria to look out for when considering a third-party solution. The white paper also includes an interactive guide to help you understand your specific needs and which option may be best for you.

Build v Buy
Fill in the form to access the link

By filling out the form, you get access to our exclusive white paper which includes an interactive guide with personalized feedback to help you decide if you should build or buy, as well as a comprehensive checklist for evaluating third-party solutions.

Contents:

1. Introduction

2. Understanding The Landscape

3. Challenges Faced By Precision Medicine Companies

4. Solution: Cloud-Based Research Platform

5. Build Versus Buy

6. Decision Time: Does The Shoe Fit

7. Conclusion

 

Data-Teams

Talk to us today

We don’t talk at you. We listen and show you the stuff you’ll value most.